pyrenedodecanoylcarnitine has been researched along with Acute Brain Injuries in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alt, J; Bedoni, M; Carlomagno, C; Gualerzi, A; Haughey, NJ; Pal, A; Picciolini, S; Rais, R; Slusher, BS; Tallon, C; Thomas, AG; Yoo, SW | 1 |
1 other study(ies) available for pyrenedodecanoylcarnitine and Acute Brain Injuries
| Article | Year |
|---|---|
Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury.
Topics: Animals; Brain Injuries; Carnitine; Corpus Striatum; Extracellular Vesicles; Injections, Intraventricular; Interleukin-1beta; Male; Mice; Mice, Transgenic; Microglia; Neurons; Oligodendroglia; Pyrenes; Sphingomyelin Phosphodiesterase | 2021 |